BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$31 | $426 | $186 | $125 |
| Dep. & Amort. | $18 | $19 | $22 | $24 |
| Deferred Tax | -$14 | $33 | $28 | $42 |
| Stock-Based Comp. | $0 | $48 | $38 | $52 |
| Change in WC | $119 | -$158 | -$90 | -$83 |
| Other Non-Cash | $276 | -$182 | -$9 | $26 |
| Operating Cash Flow | $369 | $185 | $174 | $186 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$34 | -$17 | -$17 | -$20 |
| Net Acquisitions | -$285 | $0 | $0 | $0 |
| Inv. Purchases | -$111 | -$113 | -$89 | -$58 |
| Inv. Sales/Matur. | $99 | $118 | $78 | $155 |
| Other Inv. Act. | $0 | -$0 | $0 | -$1 |
| Investing Cash Flow | -$331 | -$13 | -$28 | $76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $8 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$39 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$12 | $0 | $3 |
| Financing Cash Flow | -$2 | -$5 | -$39 | $3 |
| Forex Effect | $1 | -$3 | -$1 | $3 |
| Net Chg. in Cash | $36 | $165 | $106 | $267 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,214 | $1,049 | $943 | $675 |
| End Cash | $1,250 | $1,214 | $1,049 | $943 |
| Free Cash Flow | $340 | $168 | $158 | $165 |